lovethespeccies,
Every time IMU needs to do their due diligence, as per the Quarterly cash flow report this morning - The parasite's all come out of the woodwork. These absolute jokes with no lives, pounce on the opportunity to bag IMU management. Why because they've stuffed up with their investments in a start up Bio company, and don't have the resources to double down in dollar cost averaging. Instead they stick around annoying the responsible and patient investors.
Does management need to see some outstanding data over the next 5 months - Sure do !
Until then give them the benefit of the doubt and go annoy someone else. Do your tax returns and declare your losses, there's something productive you can create in your lives !
You've all been asked politely, by me and many others to move on repeatedly. GO !
I will not be replying to any losers !
-GO IMU!
Not Financial Advice - Opinions Only - DYOR !
- Forums
- ASX - By Stock
- IMU
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-44
-
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $357.0M |
Open | High | Low | Value | Volume |
4.8¢ | 4.8¢ | 4.7¢ | $379.2K | 7.937M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 3773908 | 4.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.8¢ | 1293222 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 3552632 | 0.047 |
23 | 3044504 | 0.046 |
30 | 3803872 | 0.045 |
40 | 6966738 | 0.044 |
29 | 3216810 | 0.043 |
Price($) | Vol. | No. |
---|---|---|
0.048 | 688107 | 6 |
0.049 | 3497564 | 11 |
0.050 | 6853048 | 24 |
0.051 | 2446049 | 14 |
0.052 | 1856295 | 13 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online